...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia
【24h】

Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia

机译:B细胞急性淋巴细胞白血病中NUP214-ABL1融合基因的游离扩增

获取原文
获取原文并翻译 | 示例

摘要

The NUP214-ABL1 fusion gene is found amplified as multiple (5-50) episomal copies in 6% of T-cell acute lymphoblastic leukemia (T-ALL). Alterations of the TLK1, TLK3, CDKN2A/B, and N0TCH1 genes are commonly associated with NUP214-ABL1 T-ALL. Recently, the NUP214-ABL1 fusion gene has been reported in 2 of 15 cases of B-cell acute lymphoblastic leukemia (B-ALL) identified by RNA-sequencing with no evidence of episomal amplification, suggesting an intrachromosomal rearrangement. In 1 of 2 cases, phosphoflow analysis demonstrated increased CRK-like protein phosphorylation, suggesting active ABL1 signaling, that was sensitive to tyrosine kinase inhibitors (TKIs). We now report the first case of B-ALL associated with extrachromosomal, episomal amplification of NUP214-ABL1. All methods can be found in supplemental Methods (available on the Blood Web site; see the Supplemental Materials link at the top of the online article).
机译:发现NUP214-ABL1融合基因在6%的T细胞急性淋巴细胞白血病(T-ALL)中扩增为多个(5-50)附加型拷贝。 TLK1,TLK3,CDKN2A / B和N0TCH1基因的改变通常与NUP214-ABL1 T-ALL相关。最近,在通过RNA测序鉴定的15例B细胞急性淋巴细胞性白血病(B-ALL)中,有2例报道了NUP214-ABL1融合基因,没有附加染色体扩增的迹象,提示染色体内重排。在2个案例中的1个案例中,磷流分析表明CRK样蛋白磷酸化增加,表明活性ABL1信号传导对酪氨酸激酶抑制剂(TKI)敏感。现在,我们报道与染色体外,游离型NUP214-ABL1扩增相关的B-ALL的第一例。所有方法都可以在补充方法中找到(可在Blood网站上找到;请参见在线文章顶部的补充材料链接)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号